Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00300261 · ClinicalTrials.gov registry record · Phase 3

Testing the Effects of Telehealth Monitoring on Rehospitalization and Self Care for Heart Failure Patients in Home Care

A Phase 3 study of Heart Failure, sponsored by University of Pennsylvania.

Completed
Registry status
Phase 3
Development phase
216
Enrollment target
1
Study location

NCT00300261: Completed Phase 3 study of Heart Failure, sponsored by University of Pennsylvania.

NCT00300261 is a Phase 3 study of Heart Failure that has completed, run by University of Pennsylvania. The registered enrollment target is 216 participants, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00300261, a Phase 3 study of Heart Failure, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
Phase 3
Development phase
216 participants
Enrollment target
1
Study location

Study Summary

We are testing the use of telehealth technology that includes self monitoring of blood pressure, weight, blood sugar, and oxygen levels for patients with heart failure who are receiving home care. We are interested to learn if using the equipment results in improved self care and decreased incidence of rehospitalization.

Conditions Studied

Interventions

  • BEHAVIORAL Telehealth monitoring

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 216 participants
Start Date 2005-09
Est. Completion 2010-06
Phase Phase 3
University of Pennsylvania

1,423 total trials

What the finished NCT00300261 record still lists

NCT00300261 is an interventional study that assigns participants to a tested intervention. The registered 216 participants enrollment target is mid-sized for trials with a published cap, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (89% lower).

The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Telehealth monitoring is the first listed.

NCT00300261 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00300261 about?

NCT00300261 is a clinical study titled "Testing the Effects of Telehealth Monitoring on Rehospitalization and Self Care for Heart Failure Patients in Home Care". We are testing the use of telehealth technology that includes self monitoring of blood pressure, weight, blood sugar, and oxygen levels for patients with heart failure who are receiving home care. We are interested to learn if using the equipment results in improved self care and decreased incidence...

What is the current status of trial NCT00300261?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 216 participants. The study started on 2005-09. Estimated completion is 2010-06.

What conditions does trial NCT00300261 study?

This clinical trial studies the following conditions: Heart Failure.

What interventions are being tested in trial NCT00300261?

The interventions under investigation include: Telehealth monitoring (BEHAVIORAL).

Who is sponsoring clinical trial NCT00300261?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00300261 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00300261's enrollment target sits among peer trials

216 159th of 397 higher than 239 of 397 other Heart Failure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02609685 · 216 participants · NA

    Active Surveillance of Papillary Thyroid Microcarcinoma

  • NCT04994873 · 216 participants · NA

    Skills to Enhance Positivity in Suicidal Youth

  • NCT05264779 · 216 participants · NA

    The Periviable GOALS Decision Support Tool

  • NCT05434130 · 216 participants · Phase 2

    Modulating Exercise Dosage to Improve Concussion Recovery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00300261, the US trial registry maintained by the National Library of Medicine. NCT00300261 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.